2019\u5e744\u67084\u65e5<\/p>\n
³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ)\u306f\u3001\u76ae\u819a\u79d1\u9818\u57df\u306b\u304a\u3051\u308b\u30b0\u30ed\u30fc\u30d0\u30eb\u5927\u624b\u4f01\u696d\u3067\u3042\u308bLEO Pharma\u793e\u304c\u3001\u88fd\u54c1\u958b\u767a\u5168\u4f53\u306e\u30a8\u30f3\u30c9\u30c4\u30fc\u30a8\u30f3\u30c9\u30d7\u30ed\u30bb\u30b9\u3092\u63a8\u9032\u3055\u305b\u308b\u305f\u3081\u306b³Ô¹Ï±¬ÁÏ Development Cloud<\/a><\/strong>\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u63a1\u7528\u3057\u305f\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u540c\u793e\u306f\u3001Vault Clinical<\/a><\/strong>\u3001Vault RIM<\/a><\/strong>\u3001\u304a\u3088\u3073Vault Quality<\/a><\/strong>\u30b9\u30a4\u30fc\u30c8\u3092\u5229\u7528\u3057\u3066\u533b\u85ac\u54c1\u958b\u767a\u3092\u5358\u4e00\u306e\u30af\u30e9\u30a6\u30c9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u7d71\u5408\u3059\u308b\u8a08\u753b\u3067\u3059\u3002³Ô¹Ï±¬ÁÏ Development Cloud\u306b\u3088\u308a\u3001LEO Pharma\u793e\u306f\u81e8\u5e8a\u8a66\u9a13\u3001\u85ac\u4e8b\u3001\u54c1\u8cea\u696d\u52d9\u7528\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u7d71\u5408\u3057\u3066\u3001\u88fd\u54c1\u958b\u767a\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u5168\u4f53\u306e\u52b9\u7387\u3068\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3092\u3055\u3089\u306b\u5411\u4e0a\u3055\u305b\u308b\u3053\u3068\u304c\u53ef\u80fd\u306b\u306a\u308a\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n <\/p>\n LEO Pharma\u793e\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u7814\u7a76\u958b\u767a\u62c5\u5f53\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3001Kim Kj\u00f8ller\u6c0f\u306f\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cLEO Pharma\u793e\u306e\u7814\u7a76\u958b\u767a\u3067\u306f2025\u5e74\u306b\u5411\u3051\u305f\u58ee\u5927\u306a\u6226\u7565\u306b\u7740\u624b\u3057\u3066\u304a\u308a\u3001\u76ae\u819a\u79d1\u5b66\u3092\u958b\u62d3\u3057\u7d9a\u3051\u308b\u3068\u3044\u3046\u5927\u671b\u3092\u5b9f\u73fe\u3059\u3079\u304f\u9053\u3092\u958b\u3053\u3046\u3068\u3057\u3066\u3044\u307e\u3059\u3002\u305d\u306e\u305f\u3081\u306b\u306f\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306b\u79d1\u5b66\u3092\u63a8\u9032\u3059\u308b\u540c\u6642\u306b\u3001\u81ea\u793e\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306e\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u9032\u6357\u3092\u4fdd\u3064\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ Development Cloud\u306b\u3088\u308a\u3001\u88fd\u54c1\u958b\u767a\u5168\u4f53\u306e\u52b9\u7387\u3092\u6700\u5927\u9650\u306b\u9ad8\u3081\u3001\u76ee\u6a19\u9054\u6210\u306b\u5411\u3051\u3066\u6210\u9577\u306b\u5fdc\u3058\u305f\u62e1\u5f35\u304c\u3067\u304d\u308b\u3001\u7d71\u5408\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u624b\u306b\u5165\u308c\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3057\u305f\u3002\u88fd\u54c1\u958b\u767a\u3092\u30b0\u30ed\u30fc\u30d0\u30eb\u3067\u30b9\u30ea\u30e0\u5316\u3057\u3001\u3055\u3089\u306b\u591a\u304f\u306e\u60a3\u8005\u69d8\u306b\u65b0\u3057\u3044\u6cbb\u7642\u6cd5\u3092\u8fc5\u901f\u306b\u63d0\u4f9b\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002\u300d<\/p>\n LEO Pharma\u793e\u306f\u30012025\u5e74\u307e\u3067\u306b1\u51042,500\u4e07\u4eba\u306e\u6162\u6027\u304a\u3088\u3073\u6025\u6027\u76ae\u819a\u75be\u60a3\u60a3\u8005\u306b\u652f\u63f4\u306e\u624b\u3092\u5dee\u3057\u4f38\u3079\u308b\u3053\u3068\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002\u540c\u793e\u306f\u3001\u533b\u85ac\u54c1\u958b\u767a\u6d3b\u52d5\u3092\u62e1\u5145\u3059\u308b\u305f\u3081\u306b\u5927\u578b\u8cb7\u53ce\u3092\u4f55\u5ea6\u3082\u65ad\u884c\u3057\u3001\u7c73\u56fd\u304a\u3088\u3073\u4e2d\u56fd\u306b\u62e0\u70b9\u3092\u8a2d\u3051\u307e\u3057\u305f\u3002³Ô¹Ï±¬ÁÏ Development Cloud\u306f\u3001LEO Pharma\u793e\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u30c1\u30fc\u30e0\u306b\u5358\u4e00\u306e\u88fd\u54c1\u958b\u767a\u60c5\u5831\u6e90\u3092\u63d0\u4f9b\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u3001\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u306e\u5411\u4e0a\u3068\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u9023\u643a\u5f37\u5316\u3092\u5b9f\u73fe\u3057\u307e\u3059\u3002<\/p>\n LEO Pharma\u793e\u30b0\u30ed\u30fc\u30d0\u30ebIT\u90e8\u9580\u306e\u30c7\u30b8\u30bf\u30eb\u30d3\u30b8\u30cd\u30b9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u62c5\u5f53\u30b7\u30cb\u30a2\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3001Mika V\u00e4lil\u00e4\u6c0f\u306f\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c³Ô¹Ï±¬ÁÏ\u306f\u5f53\u793e\u306e\u7814\u7a76\u958b\u767a\u696d\u52d9\u5168\u4f53\u306e\u5909\u9769\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u304f\u308c\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ Development Cloud\u306b\u3088\u308a\u3001\u88fd\u54c1\u958b\u767a\u6d3b\u52d5\u5168\u4f53\u306b\u308f\u305f\u3063\u3066\u81e8\u5e8a\u8a66\u9a13\u3001\u85ac\u4e8b\u3001\u54c1\u8cea\u696d\u52d9\u306b\u304a\u3051\u308b\u4e00\u8cab\u6027\u3068\u751f\u7523\u6027\u3092\u3088\u308a\u4e00\u5c64\u5411\u4e0a\u3055\u305b\u308b\u3053\u3068\u304c\u53ef\u80fd\u306b\u306a\u308a\u307e\u3057\u305f\u3002\u300d<\/p>\n \u73fe\u5728\u3001LEO Pharma\u793e\u3067\u306fVault eTMF<\/a><\/strong>\u3001Vault Submissions<\/a><\/strong>\u3001\u304a\u3088\u3073Vault QualityDocs<\/a><\/strong>\u3092\u5229\u7528\u3057\u3066\u3044\u307e\u3059\u30022019\u5e74\u306b\u306f\u3055\u3089\u306b\u3001Vault CTMS<\/a><\/strong>\u3001Vault Study Startup<\/a><\/strong>\u3001Vault Registrations<\/a><\/strong>\u3001Vault QMS<\/a><\/strong>\u3092\u8ffd\u52a0\u3057\u3066\u3001\u5730\u57df\u3084\u90e8\u9580\u3092\u8d85\u3048\u305f\u88fd\u54c1\u958b\u767a\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u306e\u3055\u3089\u306a\u308b\u30b9\u30ea\u30e0\u5316\u3092\u9032\u3081\u308b\u8a08\u753b\u3067\u3059\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ\u306e\u6b27\u5dde\u5730\u57df³Ô¹Ï±¬ÁÏ Development Cloud\u6226\u7565\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3001Rik Van Mol\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cLEO Pharma\u793e\u306f\u3001\u4f01\u696d\u304c\u3044\u304b\u306b\u3057\u3066\u91cd\u8981\u306a\u696d\u52d9\u6a5f\u80fd\u3092\u6700\u65b0\u5316\u3057\u3066\u3044\u304f\u304b\u3092\u793a\u3059\u7d20\u6674\u3089\u3057\u3044\u4f8b\u3067\u3059\u3002³Ô¹Ï±¬ÁÏ Development Cloud\u306f\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u306b\u533b\u85ac\u54c1\u958b\u767a\u5168\u4f53\u306b\u308f\u305f\u3063\u3066\u30b7\u30b9\u30c6\u30e0\u3001\u30b5\u30a4\u30c8\u3001\u304a\u3088\u3073\u56fd\u306b\u304a\u3051\u308b\u30b5\u30a4\u30ed\u5316\u3092\u89e3\u6d88\u3059\u308b\u305f\u3081\u306e\u57fa\u76e4\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u300d<\/p>\n <\/p>\n \u3010³Ô¹Ï±¬ÁÏ Systems\u793e\u306b\u3064\u3044\u3066\u3011 \u3010Forward-looking Statements\u3011<\/strong> 2019\u5e744\u67084\u65e5 ³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e ³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 …<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-42452","post","type-post","status-publish","format-standard","hentry","category-press-release","category-case-study","blog-product-content-management","blog-product-veeva-rd","blog-product-veeva-vault"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42452"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=42452"}],"version-history":[{"count":3,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42452\/revisions"}],"predecessor-version":[{"id":42494,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42452\/revisions\/42494"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=42452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=42452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=42452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n<\/strong>³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u3084\u305d\u306e\u4ed6\u306e\u898f\u5236\u3092\u53d7\u3051\u308b\u88fd\u9020\u696d\u8005\u5411\u3051\u306b\u3001\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067700\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended October 31, 2018. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"